These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6358613)

  • 1. [Metabolic and vascular consequences of hormonal contraception in non-diabetics].
    Basdevant A; Guy-Grand B
    Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613
    [No Abstract]   [Full Text] [Related]  

  • 2. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogen therapy for the climateric and thromboembolic risk].
    Campagnoli C; Prelato L; Rossetti MG
    Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and the risk of venous thrombosis.
    Vandenbroucke JP; Rosing J; Bloemenkamp KW; Middeldorp S; Helmerhorst FM; Bouma BN; Rosendaal FR
    N Engl J Med; 2001 May; 344(20):1527-35. PubMed ID: 11357157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives and diabetes].
    Bargero G; Capra Marzani M; Fasano M; Rosso A
    Minerva Med; 1986 May; 77(19):839-42. PubMed ID: 3520394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should the use of oral contraceptives be stopped by the age of 40?].
    Halttunen M
    Duodecim; 2002; 118(16):1629-30. PubMed ID: 12271939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Oral contraception, glucid metabolism and monitoring criteria].
    Gaspard U
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic side-effects of oral contraceptives.
    Doar JW
    Clin Endocrinol Metab; 1973 Nov; 2(3):503-25. PubMed ID: 4591141
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined oral estrogen / progestin contraception: practical attitude. Vascular attacks and contraception].
    Chanu B
    Arteres Veines; 1993; 12(3):176-9. PubMed ID: 12288298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on oral contraceptives.
    Hanson M; Hatcher RA; Mishell DR; Notelovitz M; Spellacy WN
    J Reprod Med; 1985 Sep; 30(9 Suppl):691-713. PubMed ID: 4057184
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular complications, lipoprotein metabolism and oral contraceptives].
    Gagné C
    Union Med Can; 1985 Oct; 114(10):865-71. PubMed ID: 4082353
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolic effects of oral contraceptives: influence of the dosage and nature of the substance used].
    Basdevant A
    Contracept Fertil Sex (Paris); 1979 Nov; 4(11):781-5. PubMed ID: 12261846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative vaginal cytology testing of gestagen components of 2 combination preparations].
    Klinger G; Ahrens P; Hempel E
    Zentralbl Gynakol; 1978; 100(10):628-31. PubMed ID: 676563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and high blood pressure: a review.
    Fregly MJ; Fregly MS
    J Fla Med Assoc; 1977 Feb; 64(2):84-91. PubMed ID: 839193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.